Alx Oncology Holdings (ALXO) Cash from Investing Activities (2019 - 2026)

Alx Oncology Holdings has reported Cash from Investing Activities for 8 years, with the latest figure at -$105.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 479.95% year-over-year to -$105.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.1 million (down 157.3% YoY) and the FY2025 annual result came in at $82.6 million, down 4.25% from the prior year.
• Cash from Investing Activities eased to -$105.0 million in Q1 2026 per ALXO's latest filing, from $11.2 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $42.3 million in Q1 2023 and troughed at -$183.9 million in Q1 2022.
• A 5-year average of -$7.5 million and a median of $12.8 million in 2023 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 3540.95% in 2022, down 2627342.86% in 2022.
• Over 5 years, Cash from Investing Activities stood at $10.9 million in 2022, then slumped by 252.31% to -$16.7 million in 2023, then surged by 299.11% to $33.2 million in 2024, then plunged by 66.15% to $11.2 million in 2025, then slumped by 1035.07% to -$105.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$105.0 million, $11.2 million, and $21.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.